ADVM - Adverum Biotechnologies, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,6121,8491,4552,319
Cost of Revenue50,13339,83930,27025,462
Gross Profit-48,521-37,990-28,815-23,143
Operating Expenses
Research Development----
Selling General and Administrative18,76019,85720,35519,707
Non Recurring----
Others----
Total Operating Expenses68,89359,69650,62545,169
Operating Income or Loss-67,281-57,847-49,170-42,850
Income from Continuing Operations
Total Other Income/Expenses Net-6,5961,700-65,352-4,603
Earnings Before Interest and Taxes-67,281-57,847-49,170-42,850
Interest Expense----
Income Before Tax-73,877-56,147-114,522-47,453
Income Tax Expense-1,250--775-
Minority Interest----
Net Income From Continuing Ops-72,627-56,147-113,747-47,453
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-72,627-56,147-113,747-47,453
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-72,627-56,147-113,747-47,453